Long-Term Quality of Life and Functional Outcome Analysis of Surgically Managed Central Neurocytoma Patients: Results of a Multicenter Study.

Date publication

octobre 2025

Journal

Neurosurgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NOEL Georges , Dr LHERMITTE Benoît , Dr CEBULA Hélène , Pr PROUST François

Tous les auteurs :
Mallereau CH, Virbel G, Pallud J, Severac F, Darlix A, Mollevi C, Lefevre E, Peyre M, Roblot P, Nicolau J, Klotz L, Sahler Y, Le Van T, Mezjan I, Choucha A, Rivollier M, Boulloud C, Page P, Picart T, Metayer T, Gavotto A, Sellier A, Claquin J, Lemée JM, Hamdan N, Todeschi J, Cebula H, Chibbaro S, Bilger M, Bauchet F, Zouaoui S, Lhermitte B, Figarella-Branger D, Rigau V, Trétarre B, Proust F, Noel G, Bauchet L,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41165331

Résumé

Central neurocytoma (CN) is a rare grade 2 intraventricular tumor according to the 2021 World Health Organization classification. Surgical resection is the recommended management. This study aimed at assessing patients' health-related quality of life (HRQoL) and functional outcomes at long-term postoperative follow-up.

Mots clés

Functional outcomes, Health-related quality of life, Neuro-oncology, Neurocytoma, Neurosurgery

Référence

Neurosurgery. 2025 10 30;: